Hikma

Amarin hit hard as generics loom for fish oil drug Vascepa

https://pharmaphorum.com/news/amarin-hit-hard-as-generics-loom-for-fish-oil-drug-vascepa/

Chasing Mylan, Hikma tries again with rejected generic Advair in US

https://pharmaphorum.com/news/chasing-mylan-hikma-tries-again-with-rejected-generic-advair-in-us/

Hikma buys potential Epipen rival from troubled Insys

https://pharmaphorum.com/news/hikma-buys-potential-epipen-generic-from-insys/

Hikma rises on cancer generic deal with China’s Hansoh

https://pharmaphorum.com/news/hikma-rises-on-cancer-generic-deal-with-chinas-hansoh/

Ex-Teva exec to be new Hikma CEO

https://pharmaphorum.com/transversal-categories/uk-and-europe/ex-teva-exec-new-hikma-ceo/

Hikma in dispute with FDA over Advair generic

https://pharmaphorum.com/news/hikma-dispute-fda-advair-generic/

GSK gets short term boost as second US Advair generic rejected

https://pharmaphorum.com/news/gsk-gets-short-term-boost-second-us-advair-generic-rejected/

Vectura and Hikma to develop US asthma generic

https://pharmaphorum.com/news/vectura-hikma-develop-us-asthma-generic/

Hikma’s new generics business has slow start

https://pharmaphorum.com/news/hikmas-new-generics-business-slow-start/

Close in 10 seconds

Pharmaphorum.com

Search